22 December 2017

Pediatric Praziquantel Consortium featured in the Japan Times

On 12 December, the date of universal health coverage day, the Japan Times featured an interview with BT Slingsby, CEO of the Tokyo-based Global Health Innovative Technology Fund. The pediatric formulation of praziquantel, developed by the Pediatric Praziquantel Consortium, was referred to as...

Dr. Kojima from Astellas, one for the founding partners of the Pediatric Praziquantel Consortium, was also interviewed by the Japan times and shared the story of the Consortium. We are delighted that our efforts continue to attract attention in Japan, especially since the seminal formulation development work by Astellas and the funding support from the GHIT Fund play an important role in our R&D program.

Click here for the article by the Japan Times.